Researchers have been excited about the medication , a novel dual agonist showing significant data in initial trials for body management. It functions by targeting both systems: GLP-1 and GIP, which , when stimulated, help control appetite and boost calorie burn. Early findings demonstrate considerable size management and potential improvements … Read More